CAH monthly performance report
Check CAH's monthly returns, drawdown, and seasonality trends — updated every month.
CAH monthly report
—
Key takeaways
- Cardinal Health (CAH) closed September 2026 at $225.38, down 3.94% for the month and +50.21% over the trailing 12 months.
- Year-to-date, CAH is +9.67%, underperforming the S&P 500 which has returned +11.70% YTD.
- The stock is trading +4.05% versus its 200-day moving average ($216.62), a bullish technical signal.
- Over the past three years, CAH has outperformed the S&P 500 by +83.92%, with a relative strength index reading of 148.9.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
Cardinal Health ended September 2026 at $225.38, posting a monthly return of −3.94%. The S&P 500 returned −0.70% over the same window, leaving relative performance at −3.24%.
The current quarter stands at −5.13% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +4.05% versus the 200-day moving average ($216.62).
Year-to-date, CAH is +9.67% against SPY +11.70%, a gap of −2.02%. The stock is currently −12.74% below its 52-week high, with maximum 3-year drawdown at −20.61%.
| Period | CAH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.42% | −0.12% | −0.30% |
| 1 Week | −3.92% | −0.34% | −3.58% |
| 1 Month | −3.94% | −0.70% | −3.24% |
| 3 Months | −1.03% | +2.80% | −3.83% |
| 6 Months | +3.82% | +13.85% | −10.03% |
| YTD | +9.67% | +11.70% | −2.02% |
| 12 Months | +50.21% | +15.01% | +35.20% |
| 3 Years | +155.62% | +71.69% | +83.92% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2025 | +21.54% |
| #2 | Jun 2026 | +20.71% |
| #3 | Nov 2023 | +17.67% |
| #4 | Nov 2024 | +12.64% |
| #5 | Aug 2024 | +11.79% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2026 | −8.72% |
| #2 | Apr 2024 | −7.92% |
| #3 | Mar 2026 | −7.82% |
| #4 | Jul 2025 | −7.61% |
| #5 | Dec 2023 | −5.86% |
| Quarter | Return |
|---|---|
| Q2 2025 | +21.94% |
| Q3 2025 | −6.57% |
| Q4 2025 | +30.93% |
| Q1 2026 | +2.83% |
| Q2 2026 | +12.42% |
| Q3 2026 (QTD) | −5.13% |
| Year | Return |
|---|---|
| 2023 | +31.13% |
| 2024 | +17.33% |
| 2025 | +73.75% |
| 2026 | +9.67% |
| Metric | Value |
|---|---|
| 52-Week High | $258.30 (2026-08-11) |
| 52-Week Low | $145.87 (2025-09-25) |
| Current Price | $225.38 |
| 200-Day Moving Average | $216.62 |
| Price vs 200DMA | +4.05% |
| 3-Year Maximum Drawdown | −20.61% (2026-05-11) |
| Current Drawdown from 52W High | −12.74% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 148.9 |
| 3-Year Excess Return vs S&P 500 | +83.92% |
| RS Peak | 168.7 (Feb 2026) |
| RS Trough | 84 (Jul 2024) |
| Status | Outperforming Benchmark |
Frequently asked questions
What was CAH's return for this report period?
CAH returned −3.94% in the latest monthly window ending 2026-09-18.
Has CAH outperformed SPY year to date?
YTD CAH: +9.67% vs SPY: +11.70%.
What is CAH's 12-month return?
+50.21% over the trailing 12 months.
Is CAH above or below its 200-day moving average?
Price is +4.05% versus 200DMA ($216.62).
What is the maximum drawdown in the 3-year window?
−20.61% on 2026-05-11.